Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Marketing
FDA slams Merz over 'misleading' Instagram ad for Botox rival
The FDA sent an untitled letter after finding fault with how Merz and an influencer handled the risks and benefits of the drug in an Instagram reel.
Nick Paul Taylor
Nov 14, 2024 9:54am
GAO takes FDA to task over lagging drug plant inspections
Nov 14, 2024 9:05am
Regulatory tracker: Sanofi aims to overturn NICE rejection
Nov 13, 2024 9:40am
FDA wants to end sale of oral phenylephrine as OTC decongestant
Nov 8, 2024 10:32am
Dr. Reddy’s recalls thyroid drug over carcinogen concerns
Nov 4, 2024 9:58am
FDA scrutinizes Novo on production issues at semaglutide plant
Oct 31, 2024 9:33am
